Position in NVS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$143,890
+$5,745 QoQ
Shares Held
942
-6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026State of Wyoming holds $5,733,697 across 12 Drug Manufacturers - General names. NVS ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
242,887 | $1,947,953 | |
| 2 | LLY |
ELI LILLY & Co
|
1,411 | $1,297,795 | |
| 3 | JNJ |
Johnson & Johnson
|
4,275 | $1,044,981 | |
| 4 | OGN |
Organon & Co.
|
54,310 | $325,316 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,188 | $263,194 | |
| 6 | BIIB |
Biogen Inc.
|
1,296 | $237,595 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,365 | $204,087 | |
| 8 | NVS |
Novartis AG
This page
|
942 | $143,890 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $143,890 | 942 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $138,145 | 1,002 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $134,908 | 1,052 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $133,353 | 1,102 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $124,857 | 1,120 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $109,960 | 1,130 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $129,972 | 1,130 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $64,940 | 610 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $58,038 | 600 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||